2013, Number 5
<< Back Next >>
salud publica mex 2013; 55 (5)
Dexamethasone and diclofenac confirmation by LC-MS-MS as herbal product adulterants
Garza-Ocañas L, Badillo-Castañeda CT, Montoya-Eguía SL, Saenz-Chávez PL, Garza-Ulloa H
Language: Spanish
References: 22
Page: 498-504
PDF size: 454.43 Kb.
ABSTRACT
Objective. To confirm the presence of dexamethasone and
diclofenac as adulterants of an herbal product.
Materials
and methods. For identificaction and confirmation of drugs
a method of instrumental analysis by liquid chromatography
coupled with high pressure tandem mass spectrometry was
used.
Results. The presence of dexamethasone and diclofenac
was confirmed in samples of 11 bottles of Reumofan Plus
obtained from patients and/or physicians. The methodology
used, allowed separation of stereoisomers dexamethasone
and betamethasone, the relative abundances of product
ions 237.2 and 279.2 m / z spectrally differentiate the compounds.
Conclusions. The presence of dexamethasone and
diclofenac was confirmed in samples of a product marketed
as “100% natural” obtained from patients and / or physicians
in a period from January to December, 2011.
REFERENCES
Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998 May 20;279(19):1548-53.
Aronson JK. Meyler’s Side Effects of Herbal Medicines, EUA: Elsevier, 2009.
Cofepris - comunicado de prensa núm. 004 México, DF., a 29 de enero de 2013 [consultado 2013 ene 29]. Disponible en: http://www.cofepris. gob.mx/Documents/NotasPrincipales/29012013.pdf
Cohen, PA. American roulette - contaminated dietary supplements. N Engl J Med 2009;361(16):1523-1525.
Bogusz, MJ, Hassan H, Al-Enazi E, Ibrahim Z, Al-Tufail, M. Application of LC–ESI–MS–MS for detection of synthetic adulterants in herbal remedies. J Pharm Biomed Anal 2006;41(2):554-564.
Petroczi A, Taylor G, Naughton DP. Mission impossible? Regulatory and enforcement issues to ensure safety of dietary supplements.” Food Chem Toxicol 2011;49(2):393-402.
Mullaicharam A. Counterfeit herbal medicine. International Journal of Nutrition, Pharmacology, Neurological Diseases 2011;1(2):97-102.
Thompson CA. Some dietary supplements resemble drugs more than food. Am J Health Syst Pharm 2012;69(9):736-737.
Gryniewicz CM, Reepmeyer JC, et al. Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry. J Pharm Biomed Anal 2009;49(3):601-606.
Farmacopea de los Estados Unidos Mexicanos. 9ª ed. México: Secretaría de Salud, Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos, 2008;1594-1596.
Patel P, Tanna S, et al. Dexamethasone quantification in dried blood spot samples using LC-MS: The potential for application to neonatal pharmacokinetic studies. J Chromatogr B 2010;878(31):3277-3282.
Fiori M, Pierdominici E, Longo F, Brambilla G. Identification of main corticosteroids as illegal feed additives in milk replacers by liquid chromatography- atmospheric pressure chemical ionization mass spectrometry. J Chromatogr A. 1998; 807(2):219-227.
Antignac, JP, Le Bizec B, Monteau F, Poulain F, André F, Collisioninduced dissociation of corticosteroids in electrospray tandem mass spectrometry and development of a screening method by high performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2000;14 (1):33-39.
2002/657/EC. Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communities, 12 agosto 2002.
Thevis M, Thomas A, Schänzer W. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 2011;401(2):405-420.
Stolker AL, Niesing W, Fuchs R, Vreeken RJ, Niessen WM, Brinkman UA. Liquid chromatography with triple-quadrupole and quadrupole-timeof- flight mass spectrometry for the determination of micro-constituents -a comparison. Anal Bioanal Chem 2004; 378(7):1754-1761.
Menchaca, A. Advierte salud contra fármacos. El Norte, 2011 abril 02, local.
Brunton L, Chabner BA, et al. Goodman and Gilman’s Pharmacological Basis of Therapeutics, Twelfth Edition (SET2), McGraw-Hill: 2010.
US Food and Drug Administration. Press Announcements - FDA issues alert on Reumofan Plus [consultado 2012 jun 01]. Disponible en: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm332 958.htm
NoMA bans herbal drugs with undeclared corticosteroids. Reactions Weekly 2004;1014:2.
Gertner E, Marshall PS, Filandrinos D, Potek AS, Smith TM. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995 may; 38(5):614-7.
Adachi M, Saito H, Kobayashi H, Horie Y, Kato S, Yoshioka M, Ishii H. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med 2003;139(6):488-92.